Viral Vector And Plasmid Dna Manufacturing Market

Viral Vector & Plasmid DNA Manufacturing - Global Market Outlook (2018-2027)

4.6 (97 reviews)
Published: April 2020 ID: SMRC19049
4.6 (97 reviews)
Published: April 2020 ID: SMRC19049

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Viral Vector & Plasmid DNA Manufacturing market is accounted for $321.60 million in 2018 and is expected to reach $1,178.24 million by 2027 growing at a CAGR of 15.1% during the forecast period. Some of the factors such as raise in alertness regarding gene therapy and raise in funding for R&D performance pertaining to gene therapy are driving the growth of the market. However, high price linked with gene therapies is likely to hamper the market growth.

Viral Vector & Plasmid DNA are commodities of gene therapy, which are used for the dealing of a great number of diseases. The advantages of gene vaccines and therapy in excess of conventional vaccines and therapies include the capacity to bring a wide variety of immune response types.  A number of clinical studies are being conducted on this market, which highlight the potential of gene therapy to deal with significant medical needs, and have initiated a surge of savings in drug expansion and commercialization of these therapies.

By vector type, plasmid DNA segment is likely to have a huge demand in the forecast period due to the clinical research applications in gene therapy and genetic vaccination. The command and therapeutic applications for plasmid DNA (pDNA) have fast grown and extended.

On the basis of geography, North America is estimated to have a huge demand owing to the growing investments in gene therapy commodities in the United States in recent years. In the United States, rigid support and patient encouragement have pressed rare illness clinical research to the centre stage.

Some of the key players in Viral Vector & Plasmid DNA Manufacturing Market include Lonza, Catapult, uniQure N.V., FUJIFILM Diosynth Biotechnologies, Kaneka Eurogentec S.A., Oxford Biomedica, Spark Therapeutics, Inc., Cobrabiologics, Merck KGaA, Brammer Bio, Cell and Gene Therapy Catapult, FinVector Vision Therapies, MassBiologics, SIRION Biotech and Thermo Fisher Scientific.

Vector Types Covered:
• Viral Vectors
• Non-Viral Vectors

Workflows Covered:
• Downstream Processing
• Upstream Processing

Diseases Covered:
• Infectious Diseases
• Cancer
• Genetic Disorders

Sales Channels Covered:
• Direct Sales
• Channel Sales

Applications Covered:
• Vaccinology
• Antisense & RNAi, & Molecular Therapy
• Cell Therapy
• Cancer
• Viral Infections
• Gene Therapy
• Inherited Disorders
• Viral Vaccines
• Protein Expression Studies
• Formulation Development

End Users Covered:
• Pharmaceutical and Biopharmaceutical Companies
• Research Institutes
• Immunotherapy
• DNA Vaccines
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.